LEVERONE JASON A. (Chief Financial Officer) sold 1.8% of their position (301.00 shares) of ONKURE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/24/2026ACC: 0001692747-26-000001
Officer· Chief Financial Officer
Since Oct 2024
-301.00
Net shares
Net seller
$1.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
301.00 disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−301.00
Price / share
$4.16
Trade value
$1.25K
% of position
1.8%
3/23/2026
16.30K→16K
Total
Net shares
−301.00
Net value
-$1.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 3/23/2026 | S · Sale | −301.00 | $4.16 | $1.25K | 1.8% | 16.30K | 16K |
| Total | −301.00 | -$1.25K | ||||||
Derivative Transactions0
No derivative transactions reported